On 26 February, Alzheimer Europe (AE) hosted a Company Round Table meeting in Brussels. It was attended by representatives from Abbvie, Biogen, Essity, Eisai, GE Healthcare, GSK, Nutricia and Roche. Also in attendance, were: 7 members of the AE staff, including Executive Director Jean Georges; 22 representatives of AE member organisations; 1 representative of the European Working Group of People with Dementia (EWGPWD); and 1 representative of the European Patients’ Forum (EPF). Cindy Birck, AE Project Officer updated sponsors and other delegates on recent developments in our Clinical Trials Watch. Following this,Eleanor newman from GSK presented some of the implications of Brexit for people with dementia and shared some of the preparations being made by GSK and other pharmaceutical companies for any eventuality at this uncertain time for the relationship between the UK and Europe. Kostas Aligiannis, EPF, talked about the Multiannual Financial Framework (MFF) and its implications for the European health and research programmes. The last speaker of the afternoon was Policy Officer Owen Miller, who presented AE’s European Dementia Pledge campaign, which aims to get MEP candidates for the May 2019 European elections, to commit to making dementia a priority. There was ample time, also, for questions and discussions after each presentation. We would like to thank our sponsors for participating in this meeting and we look forward to welcoming to the next Company Round Table meeting, in June.